Ignite Creation Date:
2024-05-06 @ 12:18 AM
Last Modification Date:
2024-10-26 @ 10:48 AM
Study NCT ID:
NCT01549340
Status:
COMPLETED
Last Update Posted:
2017-03-03
First Post:
2012-03-06
Brief Title:
Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy MK-7243-022
Sponsor:
ALK-Abelló AS
Organization:
ALK-Abelló AS
Study Overview
Official Title:
Evaluation of Patient Initiation and Persistence With Advised Allergen Immunotherapy
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the proportion of participants that initiate allergen immunotherapy AIT upon the recommendation of their physician and the proportion of participants that persist with their AIT throughout the recommended course
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None